EFFICACY AND SAFETY OF ERAXIS™/ECALTA® (ANIDULAFUNGIN) COMPARED TO CANCIDAS® (CASPOFUNGIN) IN PATIENTS WITH CANDIDA DEEP TISSUE INFECTION

Update Il y a 4 ans
Reference: EUCTR2008-005278-11

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

• To assess the efficacy of anidulafungin and caspofungin with respect to the overall global response (clinical and microbiological success) at the EOT in subjects with a confirmed diagnosis of deep tissue infection due to Candida sp.


Inclusion criteria

  • INVASIVE CANDIDIA INFECTIONS